MyOme Launches CASRcade, a No Charge Family Cascade Genetic Testing Program for Families Affected by ADH1

Summary

MyOme announced the launch of CASRcade, a no-charge family cascade genetic testing program providing genetic testing and counseling support for biological relatives of individuals with Autosomal Dominant Hypocalcemia Type 1 in the U.S.